These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38656637)

  • 1. miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2.
    Wang B; Xu Y; Huang Y; Shao S; Xu D; Zhang Y; Pang L; Nan Z; Ye Q; Wang Y; Wang W; Jin K; Yuan L
    Cardiovasc Drugs Ther; 2024 Apr; ():. PubMed ID: 38656637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
    Zhao TF; Wang SY; Zou XZ; Zhao HD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
    Zhang S; Liu J; Zheng K; Chen L; Sun Y; Yao Z; Sun Y; Lin Y; Lin K; Yuan L
    Vascul Pharmacol; 2021 Feb; 136():106820. PubMed ID: 33238205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
    Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J
    Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
    Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
    Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
    Su H; Zhu H; Wang S; Li Y; Yan C; Wang J; Ying K
    Respir Res; 2023 Jun; 24(1):165. PubMed ID: 37344798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.
    Wang G; Tao X; Peng L
    Bioengineered; 2022 May; 13(5):12985-12997. PubMed ID: 35611851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
    Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
    Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment.
    Wang J; Jiang R; Tan Y; Cheng K
    Cell Cycle; 2022 Jun; 21(11):1212-1221. PubMed ID: 35244512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
    Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
    J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension.
    Luo L; Xiao L; Lian G; Wang H; Xie L
    Aging (Albany NY); 2020 May; 12(10):9014-9030. PubMed ID: 32427576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3β/β-catenin axis.
    Yuan J; Li S; Han Y; Li F; Shi H; Shi W; Cui W
    Int Immunopharmacol; 2023 Oct; 123():110599. PubMed ID: 37567011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed lncRNA AC068039.4 Contributes to Proliferation and Cell Cycle Progression of Pulmonary Artery Smooth Muscle Cells Via Sponging miR-26a-5p/TRPC6 in Hypoxic Pulmonary Arterial Hypertension.
    Qin Y; Zhu B; Li L; Wang D; Qiao Y; Liu B; Luo E; Hou J; Yan G; Tang C
    Shock; 2021 Feb; 55(2):244-255. PubMed ID: 33026218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
    Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
    J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
    Yang Z; Li P; Yuan Q; Wang X; Ma HH; Zhuan B
    Respir Res; 2023 Mar; 24(1):92. PubMed ID: 36964568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
    Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
    Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-21-5p/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension.
    Hu X; Wang Q; Zhao H; Wu W; Zhao Q; Jiang R; Liu J; Wang L; Yuan P
    Animal Model Exp Med; 2022 Sep; 5(3):217-226. PubMed ID: 35713208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
    Zeng Z; Yao J; Li Y; Xue Y; Zou Y; Shu Z; Jiao Z
    J Cell Biochem; 2018 Feb; 119(2):2144-2155. PubMed ID: 28862358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis.
    Yi L; Liu J; Deng M; Zuo H; Li M
    BMC Pulm Med; 2021 Jul; 21(1):252. PubMed ID: 34332565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA miR-627-5p restrains pulmonary artery smooth muscle cell dysfunction by targeting MAP 2 K4 and PI3K/AKT signaling.
    Li T; Tan X; Huang Y; Cui J; Chen F; Xiong Y
    Genes Environ; 2022 Sep; 44(1):23. PubMed ID: 36163195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.